MED12 somatic mutations in fibroadenomas and phyllodes tumours of the breast.

TitleMED12 somatic mutations in fibroadenomas and phyllodes tumours of the breast.
Publication TypeJournal Article
Year of Publication2015
AuthorsPiscuoglio S, Murray M, Fusco N, Marchiò C, Loo FL, Martelotto LG, Schultheis AM, Akram M, Weigelt B, Brogi E, Reis-Filho JS
JournalHistopathology
Volume67
Issue5
Pagination719-29
Date Published2015 Nov
ISSN1365-2559
KeywordsBreast Neoplasms, Female, Fibroadenoma, High-Throughput Nucleotide Sequencing, Humans, Mediator Complex, Microdissection, Mutation, Phyllodes Tumor, Reverse Transcriptase Polymerase Chain Reaction
Abstract

AIMS: Somatic mutations in exon 2 of the mediator complex subunit 12 (MED12) gene have been identified in 60% of breast fibroadenomas (FAs). The aim of this study was to define whether phyllodes tumours (PTs) would harbour MED12 somatic mutations in a way akin to FAs.

METHODS AND RESULTS: A collection of 73 fibroepithelial tumours (including 26 FAs, 25 benign PTs, nine borderline PTs and 13 malignant PTs) from 64 patients was retrieved from the authors' institution. Sections from formalin-fixed paraffin-embedded (FFPE) blocks were microdissected to ensure an enrichment in neoplastic stromal elements of >70%. DNA samples extracted from tumour and matched normal tissues were subjected to Sanger sequencing of exon 2 of the MED12 gene. MED12 exon 2 somatic mutations, including 28 somatic single nucleotide variants and 19 insertions and deletions, were found in 65%, 88%, 78% and 8% of FAs, benign PTs, borderline PTs and malignant PTs, respectively. Malignant PTs harboured MED12 exon 2 somatic mutations significantly less frequently than FAs, benign and borderline PTs.

CONCLUSIONS: Although MED12 exon 2 somatic mutations probably constitute the driver genetic event of most FAs, benign and borderline PTs, our results suggest that the majority of malignant PTs may be driven by other genetic/epigenetic alterations.

DOI10.1111/his.12712
Alternate JournalHistopathology
PubMed ID25855048
PubMed Central IDPMC4996373
Grant ListP30 CA008748 / CA / NCI NIH HHS / United States
Related Faculty: 
Florence L. Loo, M.D.

Pathology & Laboratory Medicine 1300 York Avenue New York, NY 10065 Phone: (212) 746-6464
Surgical Pathology: (212) 746-2700